Comparing patient empowerment with standard follow-up for scoliosis
"The (Cost-)Effectiveness of a Patient Empowered Protocol Without Routine X-rays for Follow-up of Adolescent Idiopathic Scoliosis Patients; A Pragmatic Randomized Trial"
This study tests if a new way of involving teens with scoliosis in their own care can help them feel better and manage their condition more effectively compared to standard follow-up visits.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 812 (estimated) |
| Ages | 10 Years to 18 Years |
| Sex | All |
| Sponsor | Radboud University Medical Center Academic / other |
| Locations | 23 sites (Zwolle, Drenthe and 22 other locations) |
| Trial ID | NCT05379127 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness and cost-effectiveness of a new patient-empowered follow-up protocol for adolescents with idiopathic scoliosis, using patient-reported outcome measures and self-assessment tools. It compares this approach to standard follow-up care in a multicenter pragmatic randomized trial involving 812 patients aged 10-18 years. The study includes three subgroups: pre-treatment, post-brace treatment, and post-surgery patients, monitored over two years to assess both clinical outcomes and economic implications.
Who should consider this trial
Good fit: Ideal candidates are adolescents aged 10-18 years diagnosed with adolescent idiopathic scoliosis who can understand Dutch and provide informed consent.
Not a fit: Patients with scoliosis who are outside the age range or do not meet the specific inclusion criteria may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance patient engagement and improve health outcomes for adolescents with scoliosis.
How similar studies have performed: Other studies have shown promising results with patient-empowered approaches in various health conditions, suggesting potential for success in this novel application.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with adolescent idiopathic scoliosis (AIS). * Age: 10-18 years old. * Patients scheduled for follow up in one of the participating centres. * Understanding of the Dutch language. * Signed informed consent. * Biplanar (Posterior-Anterior \[PA\] and Lateral) full-spine x-rays within the last 3 months. Specifically for the pre-treatment group: * Girls aged ≤14 years (i.e. 10-14 years) and boys \<16 years (i.e. 10-15 years). These patients still have generally 2 years of remaining skeletal growth. Patients above this age with a curve below 25 degrees have a limited risk for progression * Girls: pre-menarche up to 6 months post-menarche (to estimate end of growth) * A primary coronal curve of 10-25 degree. Specifically for the post-brace group: * Patients aged 12-18 years * Within 3 months after termination of brace treatment * Minimum of 6 months of brace treatment Specifically for the post-surgery group: • Patients aged 12-18 years Exclusion Criteria: * Patients with juvenile or infantile idiopathic scoliosis with the diagnosis of onset under the age of 10. * Patients who are undergoing brace treatment. These patients are not included because of the need to monitor brace therapy with radiographs. * Patients who have undergone previous spinal surgery and are undergoing revision surgery. * Skeletally mature patients.
Where this trial is running
Zwolle, Drenthe and 22 other locations
- Isala — Zwolle, Drenthe, Netherlands (Recruiting)
- Flevo ziekenhuis — Almere, Flevoland, Netherlands (Recruiting)
- Rijnstate — Arnhem, Gelderland, Netherlands (Not_yet_recruiting)
- St Jansdal — Harderwijk, Gelderland, Netherlands (Not_yet_recruiting)
- Maastricht UMC+ — Maastricht, Limburg, Netherlands (Recruiting)
- Viecuri — Venlo, Limburg, Netherlands (Recruiting)
- Sint Maartenskliniek — Boxmeer, Noord-Brabant, Netherlands (Recruiting)
- Amphia — Breda, Noord-Brabant, Netherlands (Recruiting)
- ETZ Elisabeth — Tilburg, Noord-Brabant, Netherlands (Not_yet_recruiting)
- Noordwestziekenhuis groep — Alkmaar, Noord-Holland, Netherlands (Not_yet_recruiting)
- Olvg — Amsterdam, Noord-Holland, Netherlands (Recruiting)
- Amsterdam UMC — Amsterdam, Noord-Holland, Netherlands (Recruiting)
- Spaarne Gasthuis — Haarlem, Noord-Holland, Netherlands (Recruiting)
- Dijklander — Hoorn, Noord-Holland, Netherlands (Not_yet_recruiting)
- Meander — Amersfoort, Utrecht, Netherlands (Recruiting)
- Juliana kinderziekenhuis — Den Haag, Zuid-Holland, Netherlands (Recruiting)
- Albert Schweitzer ziekenhuis — Dordrecht, Zuid-Holland, Netherlands (Recruiting)
- Groene Hart ziekenhuis — Gouda, Zuid-Holland, Netherlands (Not_yet_recruiting)
- Leiden UMC — Leiden, Zuid-holland, Netherlands (Recruiting)
- Erasmus MC — Rotterdam, Zuid-Holland, Netherlands (Recruiting)
- Maasstad ziekenhuis — Rotterdam, Zuid-Holland, Netherlands (Recruiting)
- UMC Groningen — Groningen, Netherlands (Recruiting)
- UMC Utrecht — Utrecht, Netherlands (Recruiting)
Study contacts
- Principal investigator: Miranda L van Hooff, PhD — Radboud University Medical Center
- Study coordinator: Miranda L van Hooff, PhD
- Email: Miranda.vanHooff@radboudumc.nl
- Phone: +31 24 361 3366
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.